Authors:
Wuorimaa, T
Dagan, R
Eskola, J
Janco, J
Ahman, H
Leroy, O
Kayhty, H
Citation: T. Wuorimaa et al., Tolerability and immunogenicity of an eleven-valent pneumococcal conjugatevaccine healthy toddlers, PEDIAT INF, 20(3), 2001, pp. 272-277
Authors:
Wuorimaa, T
Kayhty, H
Eskola, J
Bloigu, A
Leroy, O
Surcel, HM
Citation: T. Wuorimaa et al., Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine, SC J IMMUN, 53(4), 2001, pp. 422-428
Authors:
Olander, RM
Wuorimaa, T
Kayhty, H
Leroy, O
Dagan, R
Eskola, J
Citation: Rm. Olander et al., Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers, VACCINE, 20(3-4), 2001, pp. 336-341
Citation: T. Wuorimaa et al., Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults, VACCINE, 19(15-16), 2001, pp. 1863-1869
Authors:
Wuorimaa, T
Dagan, R
Vakevainen, M
Bailleux, F
Haikala, R
Yaich, M
Eskola, J
Kayhty, H
Citation: T. Wuorimaa et al., Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant, J INFEC DIS, 184(9), 2001, pp. 1211-1215
Authors:
Parkkali, T
Kayhty, H
Antilla, M
Ruutu, T
Wuorimaa, T
Soininen, A
Volin, L
Ruutu, P
Citation: T. Parkkali et al., IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines, BONE MAR TR, 24(6), 1999, pp. 671-678